chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bump, described as red welt at injection site, right arm, after second vaccine; Bump, described as red welt at injection site, right arm, after second vaccine; Right arm, was sore and burning, after second vaccine; Right arm, was sore and burning, after second vaccine; Itching, after second vaccine; Arm felt hot, after second vaccine; This is a spontaneous report from a contactable consumer (patient).   A 69-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EP8731), via an unspecified route of administration, administered in right arm on 24Apr2021 at 11:00 (at the age of 69-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included ongoing nerve pain, ongoing Vitamin D deficiency, degenerative joint disease that causes the pain in her back, she had pain from a torn meniscus in her knee, pain 4 years ago and Covid virus in Jun2020 before vaccines. Concomitant medications included tramadol (TRAMADOL) taken 50 mg as needed orally for pain from an unspecified start date started 2 years ago and ongoing; gabapentin (GABAPENTIN) taken 300 mg, 3 times per day orally for nerve pain from an unspecified start date from 2 or 3 years ago and ongoing; colecalciferol (VITAMIN D3) taken 5000 UNK, 1 times per day for Vitamin D deficiency from an unspecified start date and ongoing; ascorbic acid, betacarotene, biotin, calcium, chromium, copper, folic acid, iodine, iron, magnesium, manganese, molybdenum, nicotinic acid, pantothenic acid, phosphorus, pyridoxine hydrochloride, retinol, riboflavin, selenium, thiamine, vitamin b12 nos, vitamin d nos, vitamin e nos, vitamin k nos, zinc (CENTRUM WOMEN 50+) taken 1 per day (2 gummy tablets by mouth once a day) for an general health from an unspecified start date and ongoing. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EP6955), via an unspecified route of administration, administered in right arm on 24Mar2021 at 11:00 (at the age of 69-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Patient had not received any vaccination within 4 weeks and no AE(s) following prior vaccination. On 25Apr2021, at the afternoon, around 1 or 2 pm, patient experienced right arm, was sore and burning, after second vaccine, arm felt hot and itching (Itching, after second vaccine, Arm felt hot, after second vaccine). On 26Apr2021, at night around 7 to 8 pm, the patient experienced bump, described as red welt at injection site, right arm, after second vaccine. Patient did not visit emergency room and physician office for the event. The outcome of the event was not recovered (worsened).  No follow-up attempts are needed. No further information is expected.
Patient presented to the ED on 3/18/2021 with superficial venous thrombosis of left arm.  Patient had second vaccination on 4/9/2021. on 4/27/2021 patient presented to the ED with myalgia. He was admitted on 4/28/2021 with fever and chills.  These visits are within 6 weeks of receiving COVID vaccination.
I woke up the next day with severe pain in my right hand, opposite of the injection site. I was unable to use my hand.  I could move my fingers, but unable to grip. The top of my hand was swollen and bluish in color, eventually turning a light brown, like a bruise.   By the 4th day my hand was fine.
Patient complained  of nausea, headache, dizziness. Patient was diaphoretic. No complaints of shortness of breath or throat swelling. Vital signs stable.
Fever 15 through 28 hours after second dose of vaccine. Fatigue 0-4 days after second dose of vaccine. Achey body (everywhere) 0-4 days after second dose of vaccine. Dull aches and soreness in my groin area, and also in my knee joints and feet, 0 days to 26 days (present day, i.e. I'm still experiencing these issues) after second dose of vaccine.
A round of patient came into the clinic from a group home. States that she asked several times is everyone here for a Pfizer vaccines. She stated everyone said yes and the shot was administered. After giving the shot she then states the patient stated that he needed a Moderna vaccine.
in the middle of the night woke up swee; This spontaneous case was reported by an other health care professional and describes the occurrence of MIDDLE INSOMNIA (in the middle of the night woke up swee) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced MIDDLE INSOMNIA (in the middle of the night woke up swee). In December 2021, MIDDLE INSOMNIA (in the middle of the night woke up swee) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient got vaccinated in the morning, and in the middle of the night patient woke up swee No concomitant medication were given. No treatment information were given.
Moderna vial was placed in fridge on 01/01/22. Moderna vial with the lot number of, 041J21A has not undergone a temperature excursion. Patient was administered Moderna booster(0.25ML) on 02/17/22 at 11:15AM. Patient has not reported to Medical Clinic with symptoms at this time.
Information was received on 06-OCT-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient was inoculated with a dose of ZOSTAVAX vaccine at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles on 09-OCT-2014. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 27-OCT-2016, the patient was treated at a hospital for the onset of a severe vesicular outbreak, accompanied by weakened immune systems, which was diagnosed as herpes zoster, or shingles. The patient was prescribed acyclovir, gabapentin, oxycodone, and FAMVIR for management of painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. Medical history and concurrent conditions were reported. On an unknown date, the patient was vaccinated with first dose of GARDASIL (dose, strength, route and lot numbers were not reported). Pharmacist reported that on an unknown date, the patient developed a plantar's wart on an unspecified foot after receiving his first dose of GARDASIL. Pharmacist stated that she "thinks" that the patient had two doses of GARDASIL already on unspecified date. Pharmacist also reported that the patient had been using over the counter salicylic acids pads for the plantar's wart on unspecified dates but the pads had not been helping. Pharmacist reported that patient was seen by his physician on an unknown date. The outcome of plantar wart was reported as not recovered. The pharmacist also stated that the plantar's wart has made it "difficult" for the patient to run and walk. Additional information has been requested.
Fever 102 X 24 hours,  Tylenol 500 mg  Chilling and shakingX 4 hours x 2 episodes Headache x 24 hours
On 8/13/2021 two days after covid vaccine I woke up experiencing what I could only describe as vertigo  , whirling spinning feeling . It is now 8/18/2021 and symptoms still persist.
5 hours after flu injection, pt complained of headache. 2 hours later pt vomited x1.  15 min later pt. vomited again. Pt. immediately felt better afterwards.  Pt is now fine.
Patient had turned from 4 years old to 5 years old mid series.  She was given a 3rd dose of 6 months through 4 year old monovalent instead of bivalent vaccine.
On about April 8th, 2021 I began to experience a sharp stabbing pain in my lower left shoulder blade that would throb persistently. My upper back and my left underarm area on my torso towards my back began to hurt and become extremely sensitive to touch. My lymph nodes in my left armpit, left collarbone, and on the left side of my neck were and still are very swollen. I initially went to the doctor on April 14th, 2021 after dealing with this pain that was getting progressively worse. I feared that I was having a pulmonary embolism or a cardiac event, and maybe even a problem with my spleen. After examination, my doctor believed the culprit to be my inflamed lymph nodes causing inflammation in the surrounding areas. My doctor sent me home with Meloxicam and Flexeril to help with my pain. On the night of April 14th, 2021 I noticed a rash under my left breast beginning to form. Over the course of the next 3 days, the rash became a cluster of blisters, I developed severe shooting pains from my left breast into my under arm area and around my back along the left side. My spine in my upper back began to feel bruised, along with my sternum which feels bruised and inflamed internally. I've been so uncomfortable that I've been having trouble sleeping. The pain also worsens after I eat, which makes eating really difficult. I made a second doctor's appointment for today, April 17th, 2021 (I was unable to get a sooner appointment) . My doctor confirmed that the rash is in fact Shingles and she prescribed me Valtrex and Percocet for the pain. I am currently taking these medications. Because I just found out my diagnosis today, I am still in severe pain and it's been 14 days since my second Pfizer vaccine. I do not have any known autoimmune disorders.
Severe malaise, chills, severe headache, flu-like symptoms, severe (L) arm tenderness, (L) arm redness from shoulder to elbow, subjective fever, irritability, malaise, Symptoms lasted 8 days,
Fever 101.3, headache, dizziness, rapid pulse, stomach ache, felt cold.
red swollen spot on the arm where dose was injected; red swollen spot on the arm where dose was injected; Initial information was received on 12-Oct-2021 regarding an unsolicited valid non-serious case from a pharmacist.  This case involves Adult (unknown gender) patient who experienced red swollen spot on the arm where dose was injected (vaccination site swelling and vaccination site erythema) when received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's medical history, medical treatments, vaccinations, concomitant medication and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot number and expiry dose not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious red swollen spot on the arm where dose was injected (vaccination site swelling and vaccination site erythema) (unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the events.  The event outcome was unknown for the event.  There will be no information available on the batch number for this case.
NAUSEA; TIREDNESS/SLUGGISHNESS; BRUISED ARM AT THE ADMINISTRATION SITE; DIZZINESS; FEELS A LITTLE OFF; HEADACHE; This spontaneous report received from a patient concerned a 40 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 03-APR-2021, the subject experienced headache. On 04-APR-2021, the subject experienced bruised arm at the administration site. On 04-APR-2021, the subject experienced dizziness. On 04-APR-2021, the subject experienced feels a little off. On 04-APR-2021, the subject experienced tiredness/sluggishness. On 06-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 06-APR-2021, was recovering from nausea, dizziness, and tiredness/sluggishness, and had not recovered from bruised arm at the administration site, and feels a little off. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard operating procedures.
Information has been received from a pharmacist concerning a newborn patient who on 22-AUG-2007 was vaccinated IM with a 0.5 ml dose of VAQTA (Lot#657842/0494U) instead of hepatitis B virus vaccine (manufacturer unknown). There were no symptoms reported. This event was a result of human error, not product confusion. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
On 6/12/01, pain up neck, shoulder and down left arm. On 6/19/01, red welts, swollen and painful on left arm and shoulder. No drainage, not pus filled and no itching. Pain resolved but welts still present.
Patient screamed almost non stop for 3 days.  She only didn't cry when she was nursing and/or sleeping after each set of vaccines.
Child received the Varivax vax. Several months later in June of 1999, he developed shingles. This dx was confirmed by his pediatrician. My son had developed shingles or zoster again as of March 6, 2000. This dx was also confirmed by our pediatrician.  There is no evidence according to our pediatrician that our son is in any way immunocompromised.
Information has been received from a physician concerning a 17 year old male (also reported as 16 year old ) who on 02-DEC-1993 was vaccinated with his first dose of MMR II and on 22-MAY-1997 was vaccinated with his second dose of MMR II. On 21-DEC-2009 the patient experienced mumps. The patient was diagnosed on 23-DEC-2009; the patient was reported as afebrile with left parotitis and swelling under left ear. First blood work performed on 24-DEC-2009 included IgM: < 1:10; IgG: 8.01 and serum amylase: 85. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a physician concerning a mother who developed severe vomiting, diarrhea and fever after her daughter was vaccinated PO with the first dose of Rotateq. Unspecified medical attention was sought. Three days after onset, the mother's events resolved. Additional information has been requested.
Redness and swelling of (L) arm 2 days after vaccine, hives to face. Has had flu 6 x before and never reacted. Can tolerate baked eggs.
nausea; fatigue; soreness in abdomen and left arm; soreness in abdomen and left arm; This is a spontaneous report from a non-contactable consumer or other non hcp. A 24-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 13May2021 as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 13May2021 the patient experienced nausea, fatigue, soreness in abdomen and left arm. The outcome of the events was resolved on an unknown date.  No follow-up attempt are possible. information about lot/batch number cannot be obtained.
5 minutes after receiving flu vaccine he felt dizzy, pale. Pt  fell to the floor, possible loss of consciousness for about 30 seconds then came around. Observed in the office for about one hour felt ok. Sent home will lie down re-elevated.
This spontaneous prospective pregnancy report as received from a registered nurse refers to a 20 year old female patient with no drug reactions/allergies. Patient's concurrent conditions included bipolar disorder. The patient became pregnant with last menstrual period (LMP) of 06-DEC-2014 and estimated date of delivery (EDD) of 12-SEP-2015. On 07-JAN-2015 the patient was inadvertently vaccinated with a dose of VARIVAX (Merck) dose: 0.5 ml, subcutaneously (lot # K006138, expiration date: 29-APR-2016). Concomitant therapies included ABILIFY (also reported as 'ABILFY'). Urine pregnancy test: positive on 07-JAN-2015. Initial exposure to VARIVAX (Merck) was at 4 weeks. The pregnancy outcome was outcome pending. The patient sought medical attention by visiting the office. No treatment was given for the event. No adverse effects reported. Additional information has been requested.
After my initial Covid vaccine shot, I had a strange sensation of tinnitus in my right ear. Sounds felt slightly deafened, like I was hearing at 75% efficiency out of that ear, but there wasn't any ringing sound for me like typical tinnitus. After my second Covid vaccine, this symptom got worse and I became more sensitive to loud noises and sounds, as well as being able to hear my heartbeat in my right ear which felt like a throbbing or pulsing sensation. This leads me to believe it is pulsatile tinnitus. The feeling comes and goes with various frequency and intensity throughout the day.
The employee received  1st dose of Pfizer Covid-19 vaccine at 14:00 pm 1/28/2021. About 5 minutes after receiving the injection, she felt itchiness of the ears, facial flushing and developed neck hives. She was taken to the MSB emergency room, where she was closely monitored. There, she was given dexamethasone 6 mg IM once, diphenhydramine 50 mg orally and famotidine 20 mg orally once. After about 2 hours of observation, he was discharged home on the following: prednisone 40 mg orally daily and diphenhydramine 25 mg q8h PRN.
p/vax pt increased pain sensation in lt upper arm, shoulder & radiation down lt arm, beginning approx 5 days p/vax;noted no discomfort immed p/vax;
Fractured knee; Cancer; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 11Mar2021 as a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient had fractured knee and cancer. The patient was hospitalized on an unspecified date in 2021 due to the fractured knee. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
potential myocarditis; severe fatigue; SOB; swelling of legs; This is a spontaneous report received from a contactable healthcare professional (patient) via COVAES. A non-pregnant 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 23Feb2021 (at the age of 50 years old; Lot Number: EN6202, unknown expiration) as 1st dose, single for COVID-19 immunisation.  The patient medical history was not reported. Concomitant medications included paracetamol (TYLENOL); bupropion hydrochloride (WELLBUTRIN); esomeprazole sodium (NEXIUM); ascorbic acid, chromium, copper, folic acid, inositol, magnesium, manganese, nicotinamide, pantothenic acid, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, vitamin b1 nos, vitamin b12 nos, vitamin e nos, zinc (MULTI VIT); and curcuma longa rhizome, piper nigrum fruit (TURMERIC +).  The patient experienced potential myocarditis on 15Mar2021. The patient cannot get into cardiology to confirm severe fatigue, SOB, and swelling of legs, which all started on 15Mar2021. The patient underwent lab tests and procedures which included PCR (nasal swab): Negative on 17Mar2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The events resulted in emergency room/department or urgent care and doctor or other healthcare professional office/clinic visit.  The patient had not yet recovered from the events.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Current information is limited and does not allow a full medical assessment.  Myocarditis was not a confirmed diagnosis, but rather a provisional diagnosis based on reported symptoms.  Case will be reassessed once receiving additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
started feeling a bit punky and nauseated.  By thursday almost couldn't stand smell or taste of food or coffee.  severe nausea and punk feelings all day, body aches.  took rolaids and tylenol for several days. was going to ER on sunday if no better.    went to bed at 7pm Sat, got up at 6am Sunday like nothing happened.
No additional AE; Patient was administered an expired dose of PROQUAD; This spontaneous report has been received from other health professional (medical assistant) referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, and previous drug reactions or allergies was not provided. Concomitant therapies included sterile diluent (STERILE DILUENT).     On 23-DEC-2021, the patient was vaccinated with expired measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin) (PROQUAD) (expired product administered) (lot # T021639 has been verified to be a valid lot number, expiration date was reported and established as 21-DEC-2021; route, vaccination scheme, and anatomical site of vaccination were not reported), 0.5 milliliters for prophylaxis.   No additional AE was reported.
Patient received a booster shot of Pfizer vaccine. The recommendation for booster is >18 & above. She hasn't shown any symptoms, signs yet.
On an unspecified date, the vaccinee received her first 20 mcg dose of Engerix-B. Subsequently, she experienced itching and hives. As of 8 November 2001, the outcomes of the adverse events were unknown.
Patient developed lip swelling 5 minutes after receiving second dose of Moderna vaccine in left deltoid. Patient was administered Benadryl 50 mg IM in right deltoid.  Monitored patient for an additional 30 minutes and lip swelling gradually went away.
Excessive coughing, talking caused severe coughing. Had to keep checking for blood in throat at the coughing was extremely aggressive. Within a week, just breathing caused severe coughing. All day, all throughout the night, while sleeping. None stop coughing for 24/7.  Coughing with my newborn in my arms.
On 6/20/23, a 16 years old female presented to the ED with moderate allergic symptoms after receiving a meningitis and tetanus vaccine characterized as nausea, dizziness, blurry vision, generalized weakness, and back pain. After treatment in the emergency department, the patient?s symptoms much improved and they are feeling well, breathing well, and without complaint.
Patient started throwing up. Was unable to sit up straight due to feeling nauseous.  Waited a few minutes to see if patient would recover from nausea. Patient did not seem to be recovering so called EMS.  Patient had to urgently use the restroom and was helped to the restroom because she was unsteady.  EMS arrived and patient was more responsive.